T3	Subject 0 48	A 43-year-old woman with multiple sclerosis (MS)
T4	Effect 53 71	nephrotic syndrome
T5	Treatment 72 166	21 months after starting treatment with interferon (IFN)-beta-1b (subcutaneous administration)
T7	Age 2 13	43-year-old
T8	Gender 14 19	woman
T9	Treat-Disorder 25 43	multiple sclerosis
T10	Drug 112 136	interferon (IFN)-beta-1b
T6	Adverse_event 49 52	had
E1	Adverse_event:T6 
T1	Time_elapsed 72 81	21 months
